About Hemogenyx Pharmaceuticals
Hemogenyx Pharmaceuticals is a company based in Buffalo (United States) founded in 2014. It operates as a HealthTech. Hemogenyx Pharmaceuticals has raised $1 million across 8 funding rounds from investors including Prevail Partners, MINT Capital and 43North. The company has 22 employees as of December 31, 2024. Hemogenyx Pharmaceuticals offers products and services including Breakthrough Therapies. Hemogenyx Pharmaceuticals operates in a competitive market with competitors including Jazz Pharmaceuticals, Revolution Medicines, Blueprint Medicines, Syndax and C4 Therapeutics, among others.
- Headquarter Buffalo, United States
- Employees 22 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Hemogenyx Pharmaceuticals Plc
-
Annual Revenue
$0 (USD)0as on Dec 31, 2024
-
Net Profit
$-7.04 M (USD)16.01as on Dec 31, 2024
-
EBITDA
$-6.38 M (USD)-3.55as on Dec 31, 2024
-
Total Equity Funding
$1 M (USD)
in 8 rounds
-
Latest Funding Round
$3.41 M (USD), Post-IPO
Feb 10, 2026
-
Investors
Prevail Partners
& 2 more
-
Employee Count
22
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Hemogenyx Pharmaceuticals
Hemogenyx Pharmaceuticals is a publicly listed company on the LSE with ticker symbol HEMO in UK, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Hemogenyx Pharmaceuticals
Hemogenyx Pharmaceuticals offers a comprehensive portfolio of products and services, including Breakthrough Therapies. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Therapies are developed for blood diseases and infections.
Unlock access to complete
Unlock access to complete
Funding Insights of Hemogenyx Pharmaceuticals
Hemogenyx Pharmaceuticals has successfully raised a total of $1M across 8 strategic funding rounds. The most recent funding activity was a Post-IPO round of $3.41 million completed in February 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 8
- Last Round Post-IPO — $3.4M
-
First Round
First Round
(31 Oct 2014)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2026 | Amount | Post-IPO - Hemogenyx Pharmaceuticals | Valuation |
investors |
|
| Mar, 2025 | Amount | Post-IPO - Hemogenyx Pharmaceuticals | Valuation |
investors |
|
| Jan, 2025 | Amount | Post-IPO - Hemogenyx Pharmaceuticals | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Hemogenyx Pharmaceuticals
Hemogenyx Pharmaceuticals has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Prevail Partners, MINT Capital and 43North. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Limited information is provided about Prevail Partners' activities.
|
Founded Year | Domain | Location | |
|
Seed-stage investments are targeted by 43North in startups.
|
Founded Year | Domain | Location | |
|
Offers secure software solutions for building platforms to clients.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Hemogenyx Pharmaceuticals
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Hemogenyx Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Hemogenyx Pharmaceuticals Comparisons
Competitors of Hemogenyx Pharmaceuticals
Hemogenyx Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Revolution Medicines, Blueprint Medicines, Syndax and C4 Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Cancer therapies are developed using selective pathway inhibitors.
|
|
| domain | founded_year | HQ Location |
Selective kinase inhibitors are developed for genomically defined cancers.
|
|
| domain | founded_year | HQ Location |
Targeted therapies for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for cancer treatment are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Hemogenyx Pharmaceuticals
Frequently Asked Questions about Hemogenyx Pharmaceuticals
When was Hemogenyx Pharmaceuticals founded?
Hemogenyx Pharmaceuticals was founded in 2014.
Where is Hemogenyx Pharmaceuticals located?
Hemogenyx Pharmaceuticals is headquartered in Buffalo, United States. It is registered at Buffalo, New York, United States.
Is Hemogenyx Pharmaceuticals a funded company?
Hemogenyx Pharmaceuticals is a funded company, having raised a total of $1M across 8 funding rounds to date. The company's 1st funding round was a Post-IPO of $425.6K, raised on Oct 31, 2014.
How many employees does Hemogenyx Pharmaceuticals have?
As of Dec 31, 2024, the latest employee count at Hemogenyx Pharmaceuticals is 22.
What does Hemogenyx Pharmaceuticals do?
Hemogenyx Pharmaceuticals is focused on the development of innovative therapies for the treatment of life-threatening blood diseases and viral infections. Research and solutions are targeted at addressing critical medical needs in the healthcare sector, particularly in biotechnology. The company operates with facilities in both the United Kingdom and the United States to advance its pipeline of therapeutic products.
Who are the top competitors of Hemogenyx Pharmaceuticals?
Hemogenyx Pharmaceuticals's top competitors include Jazz Pharmaceuticals, C4 Therapeutics and argenx.
What products or services does Hemogenyx Pharmaceuticals offer?
Hemogenyx Pharmaceuticals offers Breakthrough Therapies.
Is Hemogenyx Pharmaceuticals publicly traded?
Yes, Hemogenyx Pharmaceuticals is publicly traded on LSE under the ticker symbol HEMO.
Who are Hemogenyx Pharmaceuticals's investors?
Hemogenyx Pharmaceuticals has 3 investors. Key investors include Prevail Partners, MINT Capital, and 43North.
What is Hemogenyx Pharmaceuticals's ticker symbol?
The ticker symbol of Hemogenyx Pharmaceuticals is HEMO on LSE.